Literature DB >> 8076581

Dyslipidemia in non-insulin-dependent diabetes mellitus.

B V Howard1, W J Howard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8076581     DOI： 10.1210/edrv-15-3-263

Source DB:  PubMed          Journal:  Endocr Rev        ISSN： 0163-769X            Impact factor:   19.871


× No keyword cloud information.
  14 in total

Review 1.  Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome.

Authors:  Jun Kusunoki; Akio Kanatani; David E Moller
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

2.  Evidence for selective effects of vanadium on adipose cell metabolism involving actions on cAMP-dependent protein kinase.

Authors:  R W Brownsey; G W Dong
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

3.  Alterations in the oxidative metabolic profile in vascular smooth muscle from hyperlipidemic and diabetic swine.

Authors:  T M Roberts; M Sturek; J L Dixon; C D Hardin
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

4.  Bile acid receptors link nutrient sensing to metabolic regulation.

Authors:  Jibiao Li; Tiangang Li
Journal:  Liver Res       Date:  2017-04-26

5.  Role of lipids in development of noninsulin-dependent diabetes mellitus: lessons learned from Pima Indians.

Authors:  P A Tataranni; L J Baier; G Paolisso; B V Howard; E Ravussin
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

Review 6.  Oral antidiabetic drug use in the elderly.

Authors:  R Bressler; D G Johnson
Journal:  Drugs Aging       Date:  1996-12       Impact factor: 3.923

7.  Implications for kidney disease in obese children and adolescents.

Authors:  Alessandra Savino; Piernicola Pelliccia; Cosimo Giannini; Tommaso de Giorgis; Ivana Cataldo; Francesco Chiarelli; Angelika Mohn
Journal:  Pediatr Nephrol       Date:  2011-02-11       Impact factor: 3.714

8.  Atorvastatin accelerates extracellular nucleotide degradation in human endothelial cells.

Authors:  Lana Osman; Mohamed Amrani; Charles Ilsley; Magdi H Yacoub; Ryszard T Smolenski
Journal:  Mol Cell Biochem       Date:  2007-12-25       Impact factor: 3.396

Review 9.  Diabetes and cardiovascular disease: focus on glucagon-like peptide-1 based therapies.

Authors:  Paul Stranges; Ujjaini Khanderia
Journal:  Ther Adv Drug Saf       Date:  2012-08

10.  Sitagliptin, a DPP-4 inhibitor, acutely inhibits intestinal lipoprotein particle secretion in healthy humans.

Authors:  Changting Xiao; Satya Dash; Cecilia Morgantini; Bruce W Patterson; Gary F Lewis
Journal:  Diabetes       Date:  2014-02-28       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.